» Articles » PMID: 23561846

Hypomorphic Mutations in PGAP2, Encoding a GPI-anchor-remodeling Protein, Cause Autosomal-recessive Intellectual Disability

Abstract

PGAP2 encodes a protein involved in remodeling the glycosylphosphatidylinositol (GPI) anchor in the Golgi apparatus. After synthesis in the endoplasmic reticulum (ER), GPI anchors are transferred to the proteins and are remodeled while transported through the Golgi to the cell membrane. Germline mutations in six genes (PIGA, PIGL, PIGM, PIGV, PIGN, and PIGO) in the ER-located part of the GPI-anchor-biosynthesis pathway have been reported, and all are associated with phenotypes extending from malformation and lethality to severe intellectual disability, epilepsy, minor dysmorphisms, and elevated alkaline phosphatase (ALP). We performed autozygosity mapping and ultra-deep sequencing followed by stringent filtering and identified two homozygous PGAP2 alterations, p.Tyr99Cys and p.Arg177Pro, in seven offspring with nonspecific autosomal-recessive intellectual disability from two consanguineous families. Rescue experiments with the altered proteins in PGAP2-deficient Chinese hamster ovary cell lines showed less expression of cell-surface GPI-anchored proteins DAF and CD59 than of the wild-type protein, substantiating the pathogenicity of the identified alterations. Furthermore, we observed a full rescue when we used strong promoters before the mutant cDNAs, suggesting a hypomorphic effect of the mutations. We report on alterations in the Golgi-located part of the GPI-anchor-biosynthesis pathway and extend the phenotypic spectrum of the GPI-anchor deficiencies to isolated intellectual disability with elevated ALP. GPI-anchor deficiencies can be interpreted within the concept of a disease family, and we propose that the severity of the phenotype is dependent on the location of the altered protein in the biosynthesis chain.

Citing Articles

A case report of -related hyperphosphatasia with impaired intellectual development syndrome in a Chinese family and literature review.

Pan Y, Ren B, Chen L, Li Q Front Pediatr. 2024; 12:1419976.

PMID: 39687712 PMC: 11646758. DOI: 10.3389/fped.2024.1419976.


Rare Genetic Developmental Disabilities: Mabry Syndrome (MIM 239300) Index Cases and Glycophosphatidylinositol (GPI) Disorders.

Thompson M, Knaus A Genes (Basel). 2024; 15(5.

PMID: 38790248 PMC: 11121671. DOI: 10.3390/genes15050619.


The clinical and genetic spectrum of inherited glycosylphosphatidylinositol deficiency disorders.

Sidpra J, Sudhakar S, Biswas A, Massey F, Turchetti V, Lau T Brain. 2024; 147(8):2775-2790.

PMID: 38456468 PMC: 11292905. DOI: 10.1093/brain/awae056.


Excluding Digenic Inheritance of and Variants in Mabry Syndrome (OMIM 239300) Patient: Phenotypic Spectrum Associated with Gene Variants in Hyperphosphatasia with Mental Retardation Syndrome-3 (HPMRS3).

Thompson M, Li X, Spencer-Manzon M, Andrade D, Murakami Y, Kinoshita T Genes (Basel). 2023; 14(2).

PMID: 36833286 PMC: 9957281. DOI: 10.3390/genes14020359.


Hyperphosphatasia with mental retardation syndrome 3: Cerebrospinal fluid abnormalities and correction with pyridoxine and Folinic acid.

Messina M, Manea E, Cullup T, Tuschl K, Batzios S JIMD Rep. 2023; 64(1):42-52.

PMID: 36636587 PMC: 9830023. DOI: 10.1002/jmd2.12347.


References
1.
Johnston J, Gropman A, Sapp J, Teer J, Martin J, Liu C . The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria. Am J Hum Genet. 2012; 90(2):295-300. PMC: 3276655. DOI: 10.1016/j.ajhg.2011.11.031. View

2.
Ng B, Hackmann K, Jones M, Eroshkin A, He P, Wiliams R . Mutations in the glycosylphosphatidylinositol gene PIGL cause CHIME syndrome. Am J Hum Genet. 2012; 90(4):685-8. PMC: 3322218. DOI: 10.1016/j.ajhg.2012.02.010. View

3.
Krawitz P, Schweiger M, Rodelsperger C, Marcelis C, Kolsch U, Meisel C . Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome. Nat Genet. 2010; 42(10):827-9. DOI: 10.1038/ng.653. View

4.
Ng P, Henikoff S . SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003; 31(13):3812-4. PMC: 168916. DOI: 10.1093/nar/gkg509. View

5.
Nozaki M, Ohishi K, Yamada N, Kinoshita T, Nagy A, Takeda J . Developmental abnormalities of glycosylphosphatidylinositol-anchor-deficient embryos revealed by Cre/loxP system. Lab Invest. 1999; 79(3):293-9. View